Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by OneBigFishon Dec 17, 2020 7:42pm
349 Views
Post# 32136948

RE:APHA/TLRY Merger: Pros & Cons

RE:APHA/TLRY Merger: Pros & ConsI'm really back and forth on this. I see the potential of the new company and we get a lot in terms of deals with very large companies like Novartis and Inbev.

But it's hard to ignore that Aphria has about 3 times the assets, similar amount of liabilities (~$700 million), 3 times the market cap. We are still very undervalued and they are quite overvalued.

I think I like the deal but I'm not sure it's a fair one.
<< Previous
Bullboard Posts
Next >>